ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026
Validation of the fullPIERS model for predicting severe maternal outcomes in preeclampsia in five Brazilian centers.
Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this study is to validate the fullPIERS (Pre-eclampsia Integrated Estimate of Risk) prognostic model in a large, multicenter cohort of Brazilian women with preeclampsia and to determine the optimal cutoff for clinical application in the Brazilian context.
methodsThis was a secondary analysis of five prospective Brazilian studies evaluating the fullPIERS model, conducted in tertiary obstetric referral centers across three geographic regions (Porto Alegre, Campinas, Recife, Belo Horizonte, and Joinville). A total of 1581 pregnant women with confirmed preeclampsia were included. The primary outcome was the occurrence of one or more severe maternal complications within 48 h of assessment. FullPIERS risk estimates were calculated using routinely collected clinical and laboratory variables. Model performance was assessed by receiver operating characteristic (ROC) curve analysis.
resultsSevere maternal complications occurred in 235 women (14.86%), with HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome being the most frequent (9.5%). The fullPIERS model demonstrated moderate discriminative ability, with an area under the ROC curve of 0.753 (95% confidence interval: 0.714-0.791). The optimal cutoff value of 2.35% yielded a sensitivity of 58.3%, specificity of 84.6%, and a negative predictive value (NPV) of 94.8%.
conclusionIn this large, geographically diverse Brazilian cohort, the fullPIERS model showed substantial clinical utility for ruling out severe maternal complications in women with preeclampsia. Its high NPV supports its use in referral decision-making and prioritization of resources. Given its reliance on routinely available clinical data, fullPIERS might serve as a valuable tool to optimize maternal care pathways, particularly in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.